Approved Hospital Formulary
Add Formweb to your mobile device
Approved Hospital Formulary
Search results for:
morphine
morphine
| Drug Name | Form | Strength | Non-Formulary | Restricted | Renal Dosing | REMS | Therapeutic Interchange | Notes |
|---|---|---|---|---|---|---|---|---|
| Kadian | CAPSULE, EXTENDED RELEASE, ORAL | 10 mg/24 hr, 20 mg/24 hr, 50 mg/24 hr | ||||||
| AVINza | CAPSULE, EXTENDED RELEASE, ORAL | 30 mg/24 hours, 45 mg/24 hr, 60 mg/24 hr | ||||||
| Morphine Sulfate | CONCENTRATE, ORAL | 20 mg/mL | ||||||
| Roxanol | CONCENTRATE, ORAL | 20 mg/mL | ||||||
| Duramorph PF | SOLUTION, INJECTABLE | 0.5 mg/mL preservative-free | ||||||
| Morphine Sulfate | SOLUTION, INJECTABLE | 2 mg/mL, 4 mg/mL, 10 mg/mL | ||||||
| Morphine Sulfate (PCA) | SOLUTION, INTRAVENOUS | 1 mg/mL-NaCl 0.9% | ||||||
| Morphine Sulfate | SOLUTION, ORAL | 10 mg/5 mL | ||||||
| Morphine Sulfate | SOLUTION, ORAL | 20 mg/5 mL | ||||||
| MS Contin | TABLET, EXTENDED RELEASE, ORAL | 15 mg/12 hr, 30 mg/12 hr, 60 mg/12 hr,100 mg/12 hours | ||||||
| Morphine Sulfate (IR) | TABLET, ORAL | 15 mg, 30 mg |
Last updated: Aug. 22, 2022
- Black Box Warning: Injection PreserveFree: 24-hour observation following epidural/intrathecal administration
- Black Box Warning: Controlled/Extended Release: Addiction, Abuse, and Misuse; Life-Threatening Respiratory Depression; Accidental Exposure; Neonatal Opioid Withdrawal Syndrome
- Do Not Crush: Enteric-coated (a; not pudding) Capsule
- Do Not Crush: Extended-release (a) Capsule - Note: may add contents of capsule to apple juice or applesauce but NOT chocolate
- Do Not Crush: Extended-release (a) Capsule - Note: do not give via N/G tube
- Do Not Crush: Extended-release (b) Tablet
- REMS: View FDA REMS Info
- REMS: FDA Med Guide Comprehensive List
Rhazdrugs: morphine
morphine